Le directeur du développement de Revolution Medicines cède des actions pour 67.940$
Read the full article on Investing.com →
KioskNews shows the publisher’s own headline, image, and summary — the full article always lives on their site, not ours.
KioskNews shows the publisher’s own headline, image, and summary — the full article always lives on their site, not ours.